<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900896</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-001</org_study_id>
    <nct_id>NCT04900896</nct_id>
  </id_info>
  <brief_title>Outcome Measures Study on an Adult Myoelectric Elbow-Wrist-Hand Orthosis</brief_title>
  <official_title>Outcome Measures Study on an Adult Myoelectric Elbow-Wrist-Hand Orthosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Myomo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Orthocare Innovations, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Geauga Rehabilitation Engineering, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Myomo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the therapeutic and functional gains of a&#xD;
      myoelectric elbow-wrist-hand orthosis for adult individuals with upper limb impairments using&#xD;
      repeated measures studies that combines both gross motion and quantitative function outcome&#xD;
      measures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the therapeutic and functional gains of a&#xD;
      myoelectric elbow-wrist-hand orthosis for adult individuals with upper limb impairments using&#xD;
      repeated measures studies that combines both gross motion and quantitative function outcome&#xD;
      measures.&#xD;
&#xD;
      The primary outcomes of this study will collect data on the participants' therapeutic and&#xD;
      functional outcome measures when using the MyoPro over time in their home. Baseline data&#xD;
      without the device will be collected prior to receiving the MyoPro. Data with and without the&#xD;
      device will then be collected at 2-weeks post fitting and then at 1-month intervals&#xD;
      thereafter for 12 months. These outcome measures will enable an understanding of the&#xD;
      participants' functional gains with and without the MyoPro and over time with the MyoPro.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Shoulder Flexion Strength</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>A manual muscle test (MMT) will be conducted to measure shoulder flexion strength of the affected arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Shoulder Abduction Strength</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>A manual muscle test (MMT) will be conducted to measure shoulder abduction strength of the affected arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Bicep Strength</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>A manual muscle test (MMT) will be conducted to measure bicep strength of the affected arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Triceps Strength</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>A manual muscle test (MMT) will be conducted to measure triceps strength of the affected arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Hand Grip Strength</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>A manual muscle test (MMT) or dynamometer will be used to measure hand grip strength of the affected arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Bicep</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Bicep muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Triceps</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Triceps muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Wrist Flexors</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Wrist flexors muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Wrist Extensors</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Wrist extensors muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Finger Flexors</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Finger flexors muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Modified Ashworth Scale: Finger Extensors</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Finger extensors muscle spasticity of the affected arm will be measured according to the Modified Ashworth Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Shoulder Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active shoulder flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Shoulder Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active shoulder extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Shoulder Abduction</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active shoulder abduction range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Shoulder Adduction</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active shoulder adduction range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Elbow Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active elbow flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Elbow Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active elbow extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Wrist Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active wrist flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Active Range of Motion: Wrist Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Active wrist extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Shoulder Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive shoulder flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Shoulder Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive shoulder extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Shoulder Abduction</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive shoulder abduction range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Shoulder Adduction</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive shoulder adduction range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Elbow Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive elbow flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Elbow Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive elbow extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Wrist Flexion</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive wrist flexion range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline to after intervention in Passive Range of Motion: Wrist Extension</measure>
    <time_frame>Once at baseline; once after intervention at midway through therapy (anticipated at 4 weeks); once after intervention at discharge from therapy (anticipated at 8 weeks)</time_frame>
    <description>Passive wrist extension range of motion of the affected arm will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Timed Tasks Score</measure>
    <time_frame>Baseline, 2-weeks post fitting, monthly for 12-months post fitting</time_frame>
    <description>Participants will complete a pre-identified battery of functional timed tasks that will be scored.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Timed Tasks Time</measure>
    <time_frame>Baseline, 2-weeks post fitting, monthly for 12-months post fitting</time_frame>
    <description>Participants will complete a pre-identified battery of functional timed tasks that will be timed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Elbow flex/extend</measure>
    <time_frame>2-weeks post fitting, monthly for 12-months post fitting</time_frame>
    <description>The number of elbow flex/extend repetitions per day will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand open/close</measure>
    <time_frame>2-weeks post fitting, monthly for 12-months post fitting</time_frame>
    <description>The number of hand open/close repetitions per day will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life rating</measure>
    <time_frame>Baseline, 2-weeks post fitting, monthly for 12-months post fitting</time_frame>
    <description>Participants will be asked to rate their quality of life.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <condition>Brachial Plexus Injury</condition>
  <condition>Spinal Cord Injuries</condition>
  <condition>Neurological Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Myoelectric Elbow-Wrist-Hand Orthosis</intervention_name>
    <description>An arm orthosis that uses myoelectric signals to control the level of mechanical assistance provided to a user's elbow and hand in order to overcome upper limb weakness or paralysis and achieve functional tasks.</description>
    <other_name>MyoProÂ®</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult with upper limb impairment caused by brachial plexus injury, stroke, or spinal cord&#xD;
        injury, or other neurological disease or injury who have no fixed upper limb contractures&#xD;
        on the affected side and have been fitted with a myoelectric Elbow-Wrist-Hand orthosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults, 18 years and older&#xD;
&#xD;
          -  Upper limb impairment caused by brachial plexus injury (BPI), any stroke (CVA), spinal&#xD;
             cord injury (SCI), or other neurological diagnoses&#xD;
&#xD;
          -  Be medically stable&#xD;
&#xD;
          -  Be in the process of being fit with a MyoPro as a first-time user&#xD;
&#xD;
          -  Has at least trace muscle activation in the elbow and wrist flexors and extensors as&#xD;
             measured by a 1/5 on a manual muscle test at targeted joints&#xD;
&#xD;
          -  Has the minimum microvolt EMG threshold to operate the MyoPro, such that the&#xD;
             individual can sustain the EMG signals above the threshold for two full seconds (both&#xD;
             at elbow and hand) for a minimum of three times within three minutes&#xD;
&#xD;
          -  Has passive range of motion within 5 degrees of terminal range for finger open and&#xD;
             close&#xD;
&#xD;
          -  Has passive range of motion within 5 degrees of terminal range for wrist flexion and&#xD;
             at least neutral for wrist extension&#xD;
&#xD;
          -  Has passive range of motion within 5 degrees of terminal range for elbow flexion and&#xD;
             extension&#xD;
&#xD;
          -  Has at least 30 degrees of active range of motion for shoulder flexion or shoulder&#xD;
             abduction&#xD;
&#xD;
          -  Able to support the weight of the MyoPro&#xD;
&#xD;
          -  Able to tolerate functional tasks for 20 min with intermittent rests without excessive&#xD;
             fatigue&#xD;
&#xD;
          -  Has intact cognition&#xD;
&#xD;
          -  Able to clearly and verbally communicate in the English language&#xD;
&#xD;
          -  Has a wireless internet connection to participate in telehealth sessions&#xD;
&#xD;
          -  Be attending therapy within four weeks of getting fit and trained with a MyoPro&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Has a body weight above 235 lbs&#xD;
&#xD;
          -  Upper limb measurements will not allow for correct fit of the orthosis.&#xD;
&#xD;
          -  Fixed upper limb contractures on affected side&#xD;
&#xD;
          -  Unable to have full passive finger opening when the wrist is in neutral&#xD;
&#xD;
          -  Severe spasticity or tone defined as 2 or higher at the wrist or fingers, or 3 or&#xD;
             higher at the elbow on the Modified Ashworth Spasticity Scale&#xD;
&#xD;
          -  Severe shoulder subluxation (greater than one finger with significant pain) or&#xD;
             shoulder dislocation&#xD;
&#xD;
          -  Passive shoulder range of motion less than 45 degrees in flexion and abduction&#xD;
&#xD;
          -  Excessive pain, hypersensitivity, or skin issues in the arm(s) that would prevent&#xD;
             wearing the MyoPro&#xD;
&#xD;
          -  Severe cognitive or psychiatric problems that might be contraindicated for training&#xD;
             and safe MyoPro use&#xD;
&#xD;
          -  Bilateral upper limb impairment&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Other conditions (e.g. history of neurological disorder other than SCI, BPI, or CVA)&#xD;
             or circumstances that would preclude safe and/or effective participation, including&#xD;
             severe sensory deficits, skin conditions, and/or other sequelae that may be&#xD;
             contraindicated for myoelectric MyoPro use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Chang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthocare Innovations, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Chang, PhD</last_name>
    <phone>425-771-0797</phone>
    <phone_ext>1007</phone_ext>
    <email>schang@orthocareinnovations.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jon Naft, CPO</last_name>
    <phone>440-285-5785</phone>
    <email>jnaft@greop.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Myomo, Inc.</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Geauga Rehabilitation Engineering, Inc.</name>
      <address>
        <city>Chardon</city>
        <state>Ohio</state>
        <zip>44024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Orthocare Innovations, LLC</name>
      <address>
        <city>Edmonds</city>
        <state>Washington</state>
        <zip>98020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 12, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

